Moscow Healthcare Purchase Linked to 2019 Tatarstan Investment Scandal
What happened
A purchase of over 50 devices and hundreds of thousands of test systems for SARS-CoV-2 by the Moscow Healthcare Department was investigated for links to a 2019 scandal in Tatarstan. The 2019 incident involved a Japanese company promising 2.5 billion rubles ($30 million) to invest in diagnostic system production within Tatarstan. This earlier agreement was highlighted for corruption and money-laundering issues.
From english.pravda.ru
Why it matters
The connection between the Moscow medical procurement and the 2019 Tatarstan investment deal suggests potential issues regarding the use of state budget funds and corruption in major regional contracts. The scandal involved alleged patenting of biochips in Europe, the USA, and Japan.
From english.pravda.ru
Who's involved
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- TatarstanSpeculative
Tatarstan might face regulatory risk regarding its governance and investment practices due to the scandal.